Draghia-Akli Ruxandra bought NVAX
March 3, 2025 · Form 4 insider transaction
Draghia-Akli Ruxandra bought 120,000 shares of Novavax, Inc. at $7.87 per share, a transaction worth $944.4K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
120,000
Price
$7.87
Total value
$944.4K
InsiderDraghia-Akli Ruxandra
RoleOfficer
CompanyNovavax, Inc. (NVAX)
Security2025 Non-statutory Stock Option NQ
Transaction codeA: Grant or award
Transaction dateMarch 3, 2025
Filing dateMarch 5, 2025
Shares owned after120,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Twenty-five percent (25%) of the shares subject to this option granted under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, vest on the first anniversary of the grant date, and the remaining seventy-five percent (75%) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date.